Cisplatin plus vindesine in advanced breast cancer: a phase II trial of the EORTC breast cancer coooperative group
- 1 May 1985
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 21 (5) , 595-599
- https://doi.org/10.1016/0277-5379(85)90087-2
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Cisplatin and vindesine combination chemotherapy in advanced malignant melanoma: an EORTC phase II studyEuropean Journal of Cancer and Clinical Oncology, 1982
- Cisplatin in the treatment of metastatic breast carcinoma A prospective randomized trial of two dosage schedulesAmerican Journal of Clinical Oncology, 1982
- High-dose dexamethasone for prevention of cis-platin-induced vomitingCancer Chemotherapy and Pharmacology, 1981
- PHASE-II STUDY OF VINDESINE IN PATIENTS WITH METASTATIC BREAST-CANCER1981
- The Role of cis-Platinum in Solid-Tumor TherapyNew England Journal of Medicine, 1979
- VINDESINE - PHASE-II STUDY IN TREATMENT OF BREAST CARCINOMA, MALIGNANT-MELANOMA, AND OTHER TUMORS1978
- PHASE-II STUDY OF CIS-DICHLORODIAMMINEPLATINUM(II) IN ADVANCED BREAST-CANCER1978
- Assessment of response to therapy in advanced breast cancer.A project of the programme on clinical oncology of the International Union against Cancer, Geneva, SwitzerlandCancer, 1977
- COMBINATION CHEMOTHERAPY INVITRO WITH CIS-DICHLORODIAMMINEPLATINUM(II)1976